Suppression of UVA-mediated release of labile iron by epicatechin - A link to lysosomal protection

被引:32
作者
Basu-Modak, Sharmila
Ali, Dalia
Gordon, Matt
Polte, Tobias
Yiakouvaki, Anthie
Pourzand, Charareh
Rice-Evans, Catherine
Tyrrell, Rex M. [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[2] Kings Coll London, Guys Kings & St Thomas Sch Biomed Sci, Wolfson Ctr Agerelated Dis, Antibiot Res Grp, London WC2R 2LS, England
关键词
catechin; UVA; iron; protection; lysosome; free radicals;
D O I
10.1016/j.freeradbiomed.2006.06.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
UVA (320-380 nm) radiation generates an oxidative stress in cells and leads to an immediate release of potentially damaging labile iron pools in human skin cells. Treatment of cultured skin fibroblasts for several hours with physiologically relevant concentrations of either epicatechin (EC), a flavonoid plant constituent present in foods, or methylated epicatechin (3'-O-methyl epicatechin, MeOEC), its major human metabolite, prevents this iron release. The similarity of the effectiveness of EC and MeOEC argues against chelation as the mechanism of iron removal. Evidence based on measurements of lysosomal integrity strongly supports the hypothesis that the catechins protect against lysosomal destruction by UVA. Such damage would normally lead to protease release, which has been previously shown to cause ferritin degradation and release of labile iron. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1197 / 1204
页数:8
相关论文
共 41 条
[1]
Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents [J].
Agarwal, R .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1051-1059
[2]
Epicatechin and its methylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts [J].
Basu-Modak, S ;
Gordon, MJ ;
Dobson, LH ;
Spencer, JPE ;
Rice-Evans, C ;
Tyrrell, RM .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 (08) :910-921
[3]
Bode AM, 2003, J BIOCHEM MOL BIOL, V36, P66
[4]
A novel iron chelator that does not induce HIF-1 activity [J].
Creighton-Gutteridge, M ;
Tyrrell, RM .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (03) :356-363
[5]
Effect of catechin O-methylated metabolites and analogues on human LDL oxidation [J].
Cren-Olivé, C ;
Teissier, E ;
Duriez, P ;
Rolando, C .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 34 (07) :850-855
[6]
Fluorescence analysis of the labile iron pool of mammalian cells [J].
Epsztejn, S ;
Kakhlon, O ;
Glickstein, H ;
Breuer, W ;
Cabantchik, ZI .
ANALYTICAL BIOCHEMISTRY, 1997, 248 (01) :31-40
[7]
Antioxidant activity of a rosemary extract and its constituents, carnosic acid, carnosol, and rosmarinic acid, in bulk oil and oil-in-water emulsion [J].
Frankel, EN ;
Huang, SW ;
Aeschbach, R ;
Prior, E .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1996, 44 (01) :131-135
[8]
THE QUANTITATIVE DISPOSITION OF 3-O-METHYL-(+)-[U-C-14]CATECHIN IN MAN FOLLOWING ORAL-ADMINISTRATION [J].
HACKETT, AM ;
GRIFFITHS, LA ;
WERMEILLE, M .
XENOBIOTICA, 1985, 15 (11) :907-914
[9]
Balancing acts: Molecular control of mammalian iron metabolism [J].
Hentze, MW ;
Muckenthaler, MU ;
Andrews, NC .
CELL, 2004, 117 (03) :285-297
[10]
Design of therapeutic chelating agents [J].
Hider, RC .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :751-754